Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
2 vehicles on file, newest listing first
7 of 7 appear on more than one
Adeel Rouf is a New York-based financier, serial SPAC sponsor, and seasoned investment professional who currently serves as President and Chief Executive Officer of Voyager Acquisition Corp., a Nasdaq-listed special purpose acquisition company, as well as President and CEO of Voyager Acquisition Corp. II, a newly organized blank check company targeting the technology, financial technology, and healthcare industries. He also holds the position of President and Chief Financial Officer of Titan Acquisition Corp., a fintech-focused SPAC that raised $277 million in its initial public offering, and serves as Managing Member of Voyager Acquisition Sponsor. Rouf has additionally been appointed as an independent director and audit committee member of Pioneer Acquisition I Corp. and is the founder of Apollo Medical Holdings LLC. Since 2020, he has been involved in more than 10 SPAC transactions, raising over $2 billion in aggregate capital, and his career encompasses handling in excess of $10 billion in transactions across private equity and M&A.
Rouf's SPAC track record includes several notable deals and exits. As founder and Chief Financial Officer of Founder SPAC, a role he held from April 2021 to September 2022, he led the company through a $321 million IPO and subsequently engineered its merger with Rubicon Technologies, a leading digital marketplace for waste and recycling, in a combined transaction valued at $1.7 billion. Under his leadership, Voyager Acquisition Corp. completed its IPO on August 9, 2024, raising $253 million with Cantor Fitzgerald as left lead underwriter, and announced a merger with Veraxa Biotech, a Switzerland-based biotechnology firm, on April 23, 2025, in a deal valued at approximately $1.59 billion that closed on June 8, 2026. He served as President, CEO, and director of Voyager Acquisition Corp. from April 2024 until June 2026. Voyager Acquisition Corp. II filed its S-1 on March 13, 2026, seeking to raise $220 million through 22 million units at $10.00 each. He has also previously held officer and director roles at Northern Revival Acquisition Corp. and other SPACs, and he has been featured as a guest on The SPAC Podcast, where he discussed topics including why global companies choose U.S. listings, the risk-reward equation for serial SPAC sponsors, why biotech and fintech are primed for SPAC deals, and lessons learned across more than 10 SPAC transactions.
Earlier in his career, Rouf worked as an investment professional at Cohen & Company Asset Management, where he developed his expertise in the SPAC structure. Before that, he was part of J.P. Morgan's Investment Banking Leveraged Finance team, focusing on high-yield and structured debt financings, and he worked at Sumitomo Mitsui Banking Corporation, advising on structured credit and project finance transactions. His international banking and private equity background, as he has noted, taught him to be robust, precise, and effective in working with multiple parties to complete complex deals. He earned a BBA in Accounting from Baruch College and holds a Master of Science in Sustainability Management and Energy Finance from Columbia University in the City of New York. Rouf is based in New York and has been recognized as a leading expert on special purpose acquisition companies, having delivered keynote addresses at Founders Network on the art of closing billion-dollar deals, where he shared frameworks for deal execution, target selection, and collaboration with senior leadership.
This record is keyed to SEC CIK 0001827541 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 59 institutional-holder rows on these vehicles, under 28 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.